Weiwei Weng
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Ubiquitin and proteasome pathways 3
- FOXO transcription factor regulation 3
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Midie Xu (31 shared papers)Cong Tan (27 shared papers)Weiqi Sheng (29 shared papers)Shujuan Ni (23 shared papers)Qiongyan Zhang (14 shared papers)Xiang Du (8 shared papers)Dan Huang (23 shared papers)Ping Wei (6 shared papers)
- Journals
- Cancer Management and Research (3 papers)Journal of Cancer (3 papers)Frontiers in Oncology (2 papers)Cancer Cell International (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiwei Weng
44 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 782
- Molecular Biology 912
- Oncology 276
- Pathology and Forensic Medicine 96
- Pulmonary and Respiratory Medicine 170
Countries citing papers authored by Weiwei Weng
This map shows the geographic impact of Weiwei Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Weng more than expected).
Fields of papers citing papers by Weiwei Weng
This network shows the impact of papers produced by Weiwei Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Weng. The network helps show where Weiwei Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 290 | |
| 2 | 2016 | 208 | |
| 3 | 2015 | 151 | |
| 4 | 2017 | 122 | |
| 5 | 2018 | 105 | |
| 6 | 2016 | 53 | |
| 7 | 2018 | 47 | |
| 8 | 2022 | 44 | |
| 9 | 2018 | 42 | |
| 10 | 2020 | 39 | |
| 11 | 2017 | 39 | |
| 12 | 2018 | 38 | |
| 13 | 2019 | 38 | |
| 14 | OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma. | 2016 | 36 |
| 15 | 2017 | 30 | |
| 16 | 2019 | 27 | |
| 17 | 2019 | 22 | |
| 18 | 2019 | 19 | |
| 19 | 2018 | 19 | |
| 20 | 2019 | 19 |
About Weiwei Weng
Weiwei Weng is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Genetic factors in colorectal cancer (4 papers), Ferroptosis and cancer prognosis (3 papers), Ubiquitin and proteasome pathways (3 papers), FOXO transcription factor regulation (3 papers), Circular RNAs in diseases (3 papers), RNA modifications and cancer (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (782 citations), Molecular Biology (912 citations), Oncology (276 citations), Pathology and Forensic Medicine (96 citations) and Pulmonary and Respiratory Medicine (170 citations). Weiwei Weng has collaborated with scholars based in China and United States. Frequent co-authors include Midie Xu, Cong Tan, Weiqi Sheng, Shujuan Ni, Qiongyan Zhang, Xiang Du, Dan Huang, Ping Wei, Yong Wu and Meng Zhang. Their work appears in journals such as Cancer Management and Research, Journal of Cancer, Frontiers in Oncology, Cancer Cell International and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.